Log In
Print
BCIQ
Print
Print this Print this
 

Epi proColon 2.0

  Manage Alerts
Collapse Summary General Information
Company Epigenomics AG
DescriptionSecond-generation colorectal cancer test based on detection of methylated DNA of the Septin 9 gene in blood plasma by real-time PCR
Molecular Target Septin 9 (SEPT9)
Mechanism of ActionDiagnostic
Latest Stage of DevelopmentMarketed
IndicationCancer, Diagnostic
Partner

Abbott Laboratories; Gamma-Dynacare Medical Laboratories; Quest Diagnostics Inc.; Sysmex Corp.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today